Valine
Research News and Information

Monday, November 23, 2009

Evidence against AMPA receptor-lacking glutamatergic synapses in the superficial dorsal horn of the rat spinal cord.

19 Oct 2009 Pure NMDA receptor (NMDAr)-mediated EPSCs, thought to correspond to "silent" glutamatergic synapses that lack AMPA receptors (AMPArs), have been observed in superficial spinal dorsal horn of neonatal but not adult rats. Recent anatomical studies ... Read more...

Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.

3 Oct 2009 BACKGROUND: Chronic kidney disease (CKD) is an established risk factor for poor outcomes in heart failure (HF). Whether proteinuria provides additional prognostic information is not known. Renin-angiotensin blockade medications improve outcomes in ... Read more...

N-type calcium channels mediate a GABA(B) presynaptic modulation in the corticostriatal synapse in turtle's paleostriatum augmentatum.

29 Sep 2009 Spikes population evoked by a paired pulse protocol were used to assess the influence of GABA(A) and GABA(B) receptors agonists and antagonists on the synaptic potentials and in the S2/S1 ratio in a paired pulse (PP) protocol in the ... Read more...

Latest indexed articles for 'Valine'

These are the very latest articles for this heading:

• Postherpetic neuralgia in herpes zoster. 2 Nov 2009
• Evidence against AMPA receptor-lacking glutamatergic synapses in the superficial dorsal horn of the rat spinal cord. 19 Oct 2009
• Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure. 3 Oct 2009
• N-type calcium channels mediate a GABA(B) presynaptic modulation in the corticostriatal synapse in turtle's paleostriatum augmentatum. 29 Sep 2009
• The effect of study design and analysis methods on recovery rates in Bell's palsy. 29 Sep 2009
• Titin phosphorylation: myocardial passive stiffness regulated by the intracellular giant. 23 Sep 2009
• Distinctly different purpura on different arms. 17 Sep 2009
• D-amino acids govern stationary phase cell wall remodeling in bacteria. 16 Sep 2009
• GABA(B) receptor activation triggers BDNF release and promotes the maturation of GABAergic synapses. 14 Sep 2009
• N-terminal aliphatic residues dictate the structure, stability, assembly, and small molecule binding of the coiled-coil region of cartilage oligomeric matrix protein. 13 Sep 2009
• Interactions between large and small subunits of different acetohydroxyacid synthase isozymes of Escherichia coli. 13 Sep 2009
• Role of renin-angiotensin system blockade in patients with diabetes mellitus. 13 Sep 2009
• Polyclonality of BRAF mutations in acquired melanocytic nevi. 12 Sep 2009
• Structural effects of clinically observed mutations in JAK2 exons 13-15: comparison with V617F and exon 12 mutations. 8 Sep 2009
• The functional Val158Met polymorphism of COMT predicts interindividual differences in brain alpha oscillations in young men. 31 Aug 2009
• The course of pain in Bell's palsy: treatment with prednisolone and valacyclovir. 30 Aug 2009
• Heart failure and cardiac involvement as isolated manifestation of familial form of transthyretin amyloidosis resulting from Val30Met mutation with no clinical signs of polyneuropathy. 30 Aug 2009
• Role of angiotensin II type 1 receptor in cerebral aneurysm formation in rats. 30 Aug 2009
• Limitations of dietary isoleucine and valine in broiler chick diets. 30 Aug 2009
• A missed point in deciphering the viral synergy between herpes simplex virus and HIV. 30 Aug 2009

See a longer list of these articles.

Technical information about 'Valine'

Definition: A branched-chain essential amino acid that has stimulant activity. It promotes muscle growth and tissue repair. It is a precursor in the penicillin biosynthetic pathway.

Chemical name: Valine

Registry Number: 7004-03-7

Descriptor UI: D014633

Alternative terms: Valine; L-Valine; L Valine;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D12.125.070.950; D12.125.142.930;

Technical Notes: /biosyn /defic /physiol permitted